2017 Emerging Tumor Markers, and Strategic Profiles of Leading Reagent and Instrument Suppliers
This 286-page report presents comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects for major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others.
The report includes an overview of the clinical significance and market needs for both current and emerging tumor markers, as well as extensive listings of companies, universities and research centers developing or marketing innovative technologies, products, and applications.
The report also presents strategic assessments of current and emerging suppliers of cancer diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Contains286 pages and 28 tables
Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.